Viking Therapeutics
VKTX
#2409
Rank
NZ$10.46 B
Marketcap
$93.94
Share price
-9.14%
Change (1 day)
456.56%
Change (1 year)

Earnings for Viking Therapeutics (VKTX)

Earnings in 2024 (TTM): -NZ$0.17 Billion

According to Viking Therapeutics 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -NZ$0.15 Billion a decrease over its 2022 earnings that were of -NZ$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Viking Therapeutics from 2014 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.17 Billion9.55%
2023 -NZ$0.15 Billion24.73%
2022 -NZ$0.12 Billion25.24%
2021 -NZ$93.83 Million39.23%
2020 -NZ$67.39 Million53.21%
2019 -NZ$43.99 Million16.84%
2018 -NZ$37.65 Million7.22%
2017 -NZ$35.11 Million39.68%
2016 -NZ$25.14 Million-37.05%
2015 -NZ$39.94 Million6.94%
2014 -NZ$37.34 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.89 Billion 424.51%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$6.42 M-103.80%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$36.6 M-121.64%๐Ÿ‡บ๐Ÿ‡ธ USA